Actively Recruiting

Age: 50Years - 90Years
All Genders
ID06298890

Ocular Surface and Corneal Morphological Changes After Cataract Surgery and Associations With Inflammatory Biomarkers

Led by Lithuanian University of Health Sciences · Updated on 2024-03-07

100

Participants Needed

1

Research Sites

69 weeks

Total Duration

On this page

Sponsors

L

Lithuanian University of Health Sciences

Lead Sponsor

S

Santen Oy

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are exploring patterns of dry eye disease (DED) after cataract surgery, focusing on changes to the eye surface and cornea, patients' personal assessment of symptoms, and links with eye inflammation and pain markers. This observational study involves adults aged 50 to 90 who have undergone uncomplicated cataract surgery performed by the same experienced surgeon, aiming to understand the long-term effects on ocular health. Participants are divided into two groups: one will use artificial tears (sodium hyaluronate 0.2%) starting 7 days before surgery and continuing for 3 months after the procedure, applied four times daily. The other group will not use any artificial tears before or after surgery. The study tracks these groups over time to compare outcomes related to eye surface lubrication and healing. Throughout the study, participants undergo multiple assessments before surgery and at 1 week, 1 month, 3 months, 6 months, and 12 months after surgery. These include evaluations of eye surface changes, corneal structure, tear composition including inflammatory markers, eye sensitivity, and visual function tests. Questionnaires about dry eye symptoms and quality of vision are also completed. The study monitors these measures to understand how cataract surgery and tear treatment affect eye health over a year.

CONDITIONS

Brief Title

The Pattern of Dry Eye Disease After Cataract Surgery

Who Can Participate

Age: 50Years - 90Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Cataract patients aged 50 to 90 years who underwent uncomplicated phacoemulsification by the same experienced surgeon
  • No underlying ocular surface diseases such as keratitis or keratoconjunctivitis
  • No previous ophthalmic surgery
Not Eligible

You will not qualify if you...

  • Patient chooses not to participate or decides to discontinue after enrolling
  • Severe dry eye disease diagnosed by symptoms and tests including TBUT less than 10 seconds, tear osmolarity above 308 mOsm/l, or positive corneal staining
  • Diagnosis of glaucoma
  • Diabetes mellitus
  • Systemic connective tissue or autoimmune diseases
  • Neurologic conditions such as stroke, Bell's palsy, Parkinson's disease, or trigeminal nerve dysfunction
  • Previous refractive surgery like LASIK or PRK
  • Use of contact lenses
  • Use of psychiatric medicines, antihistamines, or hormonal replacement
  • Regular use of topical eye drops or ointments already in place

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Implementation

Duration - Approximately 3 months

Participants who will use artificial tears start using them 7 days before cataract surgery and continue for 3 months after surgery. Participants who do not use artificial tears undergo cataract surgery without this intervention.

Visits at 7 days preoperative, 1 week, 1 month, and 3 months postoperative

Long-term Monitoring

Duration - Up to 12 months postoperative

Participants are monitored for ocular surface and corneal changes as well as biomarker evaluations up to 12 months after cataract surgery.

Visits at 6 and 12 months postoperative

Trial Site Locations

Total: 1 location

1

Lithuanian University of Health Sciences

Kaunas, Lithuania, LT-44307

Actively Recruiting

Loading map...

Research Team

R

Reda Zemaitiene

L

Laura Kapitanovaite

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

Identifying Novel Treatment Targets and Biomarkers for Ocula...

Dry Eye Disease

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here